Mackenzie Financial
RYTM icon

Mackenzie Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Mackenzie Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,398
Closed -$469K – 1709
2025
Q4 		$469K Hold
4,398
– – ﹤0.01% 1236
2025
Q3 		$444K Sell
4,398
-13
-0.3% -$1.21K ﹤0.01% 1278
2025
Q2 		$279K Buy
4,411
+68
+2% +$4.16K ﹤0.01% 1427
2025
Q1 		$230K Hold
4,343
– – ﹤0.01% 1469
2024
Q4 		$243K Hold
4,343
– – ﹤0.01% 1472
2024
Q3 		$228K Buy
+4,343
New +$208K ﹤0.01% 1320

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Mackenzie Financial's RYTM Position: Q1 2026 in Review

Mackenzie Financial sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 4,398 shares — an estimated $469K sold.

Mackenzie Financial first reported a position in RYTM in Q3 2024 and held it in 6 quarters. The position peaked at $469K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Mackenzie Financial reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 4,398 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $469K.
  • Mackenzie Financial first reported a position in Rhythm Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Mackenzie Financial's Rhythm Pharmaceuticals position peaked at $469K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.